Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sun’s ‘Game Changing’ Dengue Drug May Launch In Four Years

This article was originally published in PharmAsia News

Executive Summary

India's Sun Pharma has said it is developing a drug derived from traditional Indian medicine that could be a ‘game-changer’ in treating dengue, one of the most rapidly spreading mosquito-borne viral diseases in the world with no current treatment.


Related Content

Data Add To Strengthening Efficacy Case For Takeda Dengue Vaccine
Sun Dips Toe Into Vaccines With Dengvaxia Challenge


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts